PURE Biosciences Inc (OTCQB:PURE)
| 0.28 Data as of May 17 |  -0.0852 / -23.33%Today’s Change | 0.26 Today|||52-Week Range 3.99 | -54.48% Year-to-Date |
Latest PURE News | Press Releases
No recent news for PURE Biosciences Inc.
Today’s Trading
| Previous close | 0.37 |
| Today’s open | 0.40 |
| Day’s range | 0.26 - 0.40 |
| Volume | 391,855 |
| Average volume (3 months) | 71,844 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +10.23% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +74.93% |
| P/E ratio | -- |
| Price/Sales | 21.07 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | June 13, 2013 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $812.0K |
| Annual profit (last year) | -$8.9M |
| Net profit margin | -1,094.83% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael L. Krall |
Chief Financial & Accounting Officer Peter C. Wulff, MBA |
Corporate headquarters El Cajon, California |
Forecasts
